Item 5. Other Information
Item
5. Other Information
None .
20
Item
6. Exhibits
Filed
or
Exhibit
Reference
Furnished
Number
Exhibit
Description
Form
Exhibit
Filing
Date
Herewith
3.1
Third
Amended and Restated Articles of Incorporation of Modular Medical, Inc., as filed with the Secretary of State of Nevada on June 27,
2017
8-K
3.1
06/29/2017
3.2
Certificate of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of the State of Nevada on November 24, 2021
8-K
3.1
12/01/2021
3.3
Certificate
of Amendment to the Amended and Restated Articles of Incorporation of Modular Medical, Inc., filed with the Secretary of State of
the State of Nevada on February 15, 2024
8-K
3.1
02/15/2024
3.4
Amended
Bylaws of Modular Medical, Inc.
10-SB
3.2
03/08/2002
4.1
Form
of Common Stock Purchase Warrant
8-K
4.1
09/23/2025
10.1
Form
of 2023 Warrant Inducement Letter
8-K
10.1
09/23/2025
10.2
Form
of 2025 Warrant Inducement Letter
8-K
10.2
09/23/2025
31.1
Certification
of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
x
31.2
Certification
of Principal Financial Officer pursuant to Section 302 of the Sarbanes- Oxley Act of 2002
x
32.1
Certification
of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
906 of the Sarbanes- Oxley Act of 2002
x
101
The
following financial information from Modular Medical, Inc.'s quarterly report on Form 10-Q for the period ended September 30, 2025,
filed with the SEC on November 14, 2025, formatted in Inline Extensible Business Reporting Language (Inline XBRL): (i) the Condensed
Consolidated Statements of Operations for the three and six months ended September 30, 2025 and 2024, (ii) the Condensed Consolidated
Balance Sheets as of September 30 2025 and March 31, 2025, (iii) the Condensed Consolidated Statements of Stockholders' Equity for
the three and six months ended September 30, 2025 and 2024, (iv) the Condensed Consolidated Statements of Cash Flows for the six
months ended September 30, 2025 and 2024, and (v) Notes to Condensed Consolidated Financial Statements.
x
104
Cover
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
21
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
MODULAR MEDICAL, INC.
Date:
November 14, 2025
By:
/s/ James
E. Besser
James
E. Besser
Chief
Executive Officer
(Principal
Executive Officer)
By:
/s/
Paul DiPerna
Paul
DiPerna
Chairman, President, Chief Financial Officer and Treasurer
(Principal Financial Officer)
22
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.